AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 186 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $5,272,890 | -75.2% | 544,720 | -71.9% | 0.02% | -75.8% |
Q1 2023 | $21,262,104 | +125.4% | 1,939,973 | -11.1% | 0.07% | +106.2% |
Q4 2022 | $9,431,191 | +130.9% | 2,183,146 | +594.0% | 0.03% | +68.4% |
Q1 2021 | $4,085,000 | -86.2% | 314,565 | -85.3% | 0.02% | -86.8% |
Q4 2020 | $29,589,000 | -14.3% | 2,139,461 | -8.7% | 0.14% | -18.6% |
Q3 2020 | $34,523,000 | -44.7% | 2,343,751 | -39.0% | 0.18% | -56.5% |
Q2 2020 | $62,461,000 | -7.8% | 3,843,741 | -17.7% | 0.41% | -26.0% |
Q1 2020 | $67,752,000 | -7.0% | 4,669,343 | +29.9% | 0.55% | +43.6% |
Q4 2019 | $72,848,000 | +62700.0% | 3,595,633 | +16429.4% | 0.38% | +38200.0% |
Q3 2019 | $116,000 | -20.0% | 21,753 | -1.5% | 0.00% | 0.0% |
Q2 2019 | $145,000 | +663.2% | 22,083 | +670.2% | 0.00% | – |
Q1 2019 | $19,000 | -99.2% | 2,867 | -99.5% | 0.00% | -100.0% |
Q4 2017 | $2,433,000 | – | 537,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blackcrane Capital, LLC | 111,608 | $2,470,000 | 3.15% |
ACT CAPITAL MANAGEMENT, LLC | 180,000 | $3,983,000 | 2.06% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 167,889 | $3,715,000 | 1.92% |
DG Capital Management, LLC | 402,200 | $8,901,000 | 1.81% |
NEA Management Company, LLC | 5,172,683 | $114,471,000 | 1.36% |
KESTRA PRIVATE WEALTH SERVICES, LLC | 801,100 | $17,728,000 | 0.99% |
Altium Capital Management LP | 144,000 | $3,187,000 | 0.84% |
HighMark Wealth Management LLC | 50,569 | $1,119,000 | 0.82% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 123,500 | $2,724,000 | 0.66% |
SEVEN EIGHT CAPITAL, LP | 288,840 | $6,392,000 | 0.62% |